Results 141 to 150 of about 666,121 (300)

Protective Effects of Imeglimin Against Oxaliplatin‐Induced Peripheral Neurotoxicity: Evidence From In Vitro and In Vivo Studies

open access: yesJournal of Applied Toxicology, EarlyView.
ABSTRACT Oxaliplatin is a platinum‐based anticancer agent widely used for gastrointestinal malignancies; however, it is known to cause dose‐dependent peripheral neuropathy (OIPN), a characteristic adverse effect. OIPN results in a reduced quality of life and often necessitates dose reduction or discontinuation of oxaliplatin; however, effective ...
Yusuke Koura   +11 more
wiley   +1 more source

Prediabetes and diabetes in relation to risk of gastric adenocarcinoma

open access: yes, 2019
Background: Whether prediabetes or diabetes increases the risk of gastric adenocarcinoma is not clear. Methods: This cohort study included 111,198 participants in the Northern Swedish Health and Disease Study.
Ingegerd Johansson   +29 more
core   +1 more source

Guidelines for Diagnosis, Reporting and Management of Intraductal Papillary Neoplasm of the Bile Duct (IPNB): Recommendations of Bangkok Consensus Meeting

open access: yesJournal of Hepato-Biliary-Pancreatic Sciences, EarlyView.
ABSTRACT Background There are no international consensus guidelines on IPNB. Method An international‐multidisciplinary panel performed a critical appraisal of the literature and used a two‐round Delphi process to evaluate 24 critical clinical questions, incorporating community feedback from a dedicated 2025 A‐PHPBA meeting session in Bangkok.
Vor Luvira   +42 more
wiley   +1 more source

A rare cause of dysphagia: A case report on gastroesophageal adenocarcinoma in childhood

open access: yesJPGN Reports, EarlyView.
Abstract Dysphagia is a common symptom in pediatric patients with a broad differential diagnosis, while gastroesophageal (GE) malignancies represent an exceptionally rare cause. We report a previously healthy 9‐year‐old female patient who presented with 1 month of progressive dysphagia, intractable vomiting, and weight loss.
Leo Fawaz   +2 more
wiley   +1 more source

Proteomic and Metabolomic Profiling Reveal Mitochondrial Transplantation–Mediated Reprogramming in Gastric Cancer Cells

open access: yesThe Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Mitochondria provide multiple functions for cellular physiology. Transplantation of mitochondria isolated from gastric epithelial cells GES‐1 reducing the malignancy of gastric cancer cells AGS was previously reported. To elucidate the underlying mechanisms, TMT‐based proteomic analysis coupling ingenuity pathway software prediction revealed ...
Ping‐Chen Chen   +9 more
wiley   +1 more source

Mucolipin TRP Cation Channel 1 Depletion Promotes Gastric Cancer Cell Ferroptosis Through the AKT Pathway

open access: yesThe Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Mucolipin TRP cation channel 1 (MCOLN1), also called TRPML1, drives the progression of various cancers and inhibits ferroptosis in a number of diseases. This study aimed to investigate whether MCOLN1 depletion regulates ferroptosis in gastric cancer and its molecular regulatory crosstalk with the AKT pathway.
Jing Wang   +5 more
wiley   +1 more source

Gastric metastasis of primary lung adenocarcinoma: a case report and review of the literature

open access: yesDiscover Oncology
Purpose Gastric metastasis from primary lung adenocarcinoma is rare. This case highlights the diagnostic challenges when lung cancer presents with gastrointestinal involvement as part of advanced metastatic disease. Case presentation A 59-year-old female
Danyang Han   +6 more
doaj   +1 more source

Unexpected Diagnosis: Gastric Adenocarcinoma Mimicking a Subepithelial Lesion

open access: yes
OBJECTIVE Gastric adenocarcinoma is one of the most common malignancies worldwide, typically presenting as ulcerated or infiltrative lesions during endoscopy.
Levent Aktaş   +2 more
core   +1 more source

Bilateral Ophthalmoplegia After Neoadjuvant Pembrolizumab for Oral Cavity Squamous Cell Carcinoma

open access: yesThe Laryngoscope, EarlyView.
The role of immune checkpoint inhibition (ICI) therapy in the treatment of head and neck squamous cell carcinoma (HNSCC) is expanding with increased utilization of neoadjuvant and adjuvant pembrolizumab in the setting of locally advanced disease. This report describes the presentation and management of the first known case of pembrolizumab‐induced ...
Leonard E. Estephan   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy